Page last updated: 2024-08-05 10:54:03

aromatic amino acid

An amino acid whose structure includes an aromatic ring.

ChEBI ID: 33856

Members (8)

MemberDefinitionRole
1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acidA member of the class of beta-carbolines that is 1,2,3,4-tetrahydro-beta-carboline substituted at position 3 by a carboxy group.1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid
4-n-butylaminobenzoic acid4-Aminobenzoic acid in which one of the hydrogens attached to the nitrogen is substituted by a butyl group.4-(butylamino)benzoic acid
bromfenacAmfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure.bromfenac
desmosinedesmosine
flufenamic acidAn aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.flufenamic acid
phenylalanineAn aromatic amino acid that is alanine in which one of the methyl hydrogens is substituted by a phenyl group.phenylalanine
robenacoxibAn aromatic amino acid that is 2-amino-5-ethylphenylacetic acid in which one of the amino hydrogens is replaced by a 2,3,5,6-tetrafluorophenyl group. A selective cyclooxygenase 2 inhibitor that is used in veterinary medicine for the relief of pain and inflammation in cats and dogs.robenacoxib
tryptophanAn alpha-amino acid that is alanine bearing an indol-3-yl substituent at position 3.tryptophan zwitterion; tryptophan

Research

Studies (1,705)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990659 (38.65)18.7374
1990's251 (14.72)18.2507
2000's297 (17.42)29.6817
2010's406 (23.81)24.3611
2020's92 (5.40)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials184 (10.27%)5.53%
Reviews61 (3.41%)6.00%
Case Studies39 (2.18%)4.05%
Observational3 (0.17%)0.25%
Other1,504 (83.98%)84.16%